SCHEMBL6995306

SCHEMBL6995306

CCOC(=O)C(C)Oc1cccc(C(F)(F)F)c1.Oc1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 2/20 0.47
PPARG P37231 6/20 0.46
PPARA Q07869 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
ALOX12 P18054 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.44
IDH1 O75874 1/20 0.44
SLC22A12 Q96S37 1/20 0.43
GRM2 Q14416 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
POLB P06746 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5207539 0.94 PPARG (0.51) LMNAL3MBTL1KDM4EPPARGPPARA
SCHEMBL6989122 0.89 LMNA (0.48) LMNAL3MBTL1SMN1; SMN2IDH1GRM2
SCHEMBL1454525 0.85 L3MBTL1 (0.57) LMNAL3MBTL1SMN1; SMN2GRM2KMT2A
SCHEMBL5205507 0.81 L3MBTL1 (0.50) LMNAL3MBTL1KDM4ESMN1; SMN2IDH1
SCHEMBL10933587 0.81 IDH1 (0.47) LMNAL3MBTL1KDM4EGAAIDH1
Metacresol SCHEMBL6989813 0.80 L3MBTL1 (0.52) LMNAL3MBTL1SMN1; SMN2KMT2AMEN1
SCHEMBL5620986 0.80 PPARG (0.51) L3MBTL1KDM4EPPARGPPARAGAA
SCHEMBL11210510 0.80 IDH1 (0.51) LMNAL3MBTL1KDM4ESMN1; SMN2IDH1
SCHEMBL11223862 0.80 NPSR1 (0.52) LMNAKDM4EPPARGPPARAGAA
SCHEMBL11265314 0.79 L3MBTL1 (0.46) LMNAL3MBTL1KDM4EPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313717-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2003-05-28 EP disclosed
WO-2002016332-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2002-02-28 WO disclosed